Atyr Pharma earnings were -$60.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ATYR earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$10.3M, down 4.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ATYR reported annual earnings of -$74.1M, with 15.8% growth.
On ATYR's earnings call on Aug 6, 2026, Atyr Pharma (NASDAQ: ATYR) reported Q2 2026 earnings per share (EPS) of -$0.11, up 50% year over year. Total ATYR earnings for the quarter were -$10.31 million. In the same quarter last year, Atyr Pharma's earnings per share (EPS) was -$0.22.
As of the last Atyr Pharma earnings report, Atyr Pharma is currently losing money. Atyr Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$60.81 million, a 8.75% decrease year over year.
What was ATYR's earnings growth in the past year?
As of Atyr Pharma's earnings date in Aug 6, 2026, Atyr Pharma's earnings has grown year over year. ATYR earnings in the past year totalled -$60.81 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.